The global demand for Transdermal Skin Patches Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
A transdermal patch is a type of transdermal technology. It is a medicated adhesive patch placed on the skin to deliver a specific dose of medication. These patches provide medication dose though the skin using the diffusion technique, which later gets released in the bloodstream over a long period. These patches are effectively used for the treatment of hormonal and cardiac disorders. These patches are also used to treat migraine, Parkinsons disease, Alzheimer's, strokes, HIV, osteoporosis, dermatology-related issues, and restless leg syndrome treatments.
The primary factor contributing to the growth of the market is the increasing advantages of transdermal medicine over the conventional way of medications (medications for gastrointestinal toxicity), resulting in nausea and vomiting. As they are non-invasive in nature, they reduce the inconvenience caused due to intravenous or parenteral therapies. The main advantage is that the patch provides a controlled release of the medication into the patient, generally through either a porous membrane covering the storage of medication or through body heat melting thin layers of medication deposited in the adhesive. Additionally, increasing funding and investments for drug development boosts the market growth. However, the skin's inability to absorb a range of active substances is expected to impede the market's growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of transdermal skin patches.
The entire transdermal skin patches market has been sub-categorized into type, application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Single-Layer Drug-in-Adhesive
- Multi-Layer Drug-in-Adhesive
- Vapour Patch
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hospitals and Clinics
- Home Care Settings
This section covers regional segmentation which accentuates on current and future demand for transdermal skin patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Transdermal Skin Patches Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the transdermal skin patches market include Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc., 3M Company, Accrux Ltd., Access Pharmaceuticals Inc., Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.